Seegene unveils world’s first commercialized ‘3 Ct’ PCR assay
Provides Ct value of three targets in one channel; ‘3 Ct’ PCR assay to launch in H1 “Dream MDx technology” developed based on Seegene’s 20-year
Provides Ct value of three targets in one channel; ‘3 Ct’ PCR assay to launch in H1 “Dream MDx technology” developed based on Seegene’s 20-year
New York, April 25, 2022 (GLOBE NEWSWIRE) — The Open Society Foundations are appalled by today’s Turkish court decision to sentence Osman Kavala—the business leader